Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Löffler Endocarditis and Endomyocardial Fibrosis.

Flanigan MJ, Velez MR, Ruden EA, Lilly SM.

J Am Osteopath Assoc. 2017 Sep 1;117(9):601. doi: 10.7556/jaoa.2017.115. No abstract available.

PMID:
28846127
2.

On-line near-infrared spectrometer to monitor urea removal in real time during hemodialysis.

Cho DS, Olesberg JT, Flanigan MJ, Arnold MA.

Appl Spectrosc. 2008 Aug;62(8):866-72. doi: 10.1366/000370208785284411.

PMID:
18702859
3.

Physician access and early nephrology care in elderly patients with end-stage renal disease.

Zhao Y, Brooks JM, Flanigan MJ, Chrischilles EA, Pendergast JF, Hunsicker LG.

Kidney Int. 2008 Dec;74(12):1596-602. doi: 10.1038/ki.2008.212. Epub 2008 May 28.

4.

How should dialysis fluid be individualized for the chronic hemodialysis patient? Sodium.

Flanigan MJ.

Semin Dial. 2008 May-Jun;21(3):226-9. doi: 10.1111/j.1525-139X.2008.00428.x. Epub 2008 Mar 18. No abstract available.

PMID:
18363598
5.
6.

Effect of dialysis center profit-status on patient survival: a comparison of risk-adjustment and instrumental variable approaches.

Brooks JM, Irwin CP, Hunsicker LG, Flanigan MJ, Chrischilles EA, Pendergast JF.

Health Serv Res. 2006 Dec;41(6):2267-89.

7.

Technology in clinical practice.

Flanigan MJ.

ASAIO J. 2005 Nov-Dec;51(6):xxxii-xxxv.

PMID:
16340347
8.

Melagatran anticoagulation during haemodialysis--'Primum non nocere'.

Flanigan MJ.

Nephrol Dial Transplant. 2005 Sep;20(9):1789-90. Epub 2005 Jul 26. Review. No abstract available.

PMID:
16046512
9.

Does hemodialysis increase protein breakdown? Dissociation between whole-body amino acid turnover and regional muscle kinetics.

Lim VS, Ikizler TA, Raj DS, Flanigan MJ.

J Am Soc Nephrol. 2005 Apr;16(4):862-8. Epub 2005 Feb 16. Review.

10.

Hormonal responses to fasting and refeeding in chronic renal failure patients.

Deshmukh S, Phillips BG, O'Dorisio T, Flanigan MJ, Lim VS.

Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E47-55. Epub 2004 Aug 10.

11.

Whole-genome shotgun assembly and comparison of human genome assemblies.

Istrail S, Sutton GG, Florea L, Halpern AL, Mobarry CM, Lippert R, Walenz B, Shatkay H, Dew I, Miller JR, Flanigan MJ, Edwards NJ, Bolanos R, Fasulo D, Halldorsson BV, Hannenhalli S, Turner R, Yooseph S, Lu F, Nusskern DR, Shue BC, Zheng XH, Zhong F, Delcher AL, Huson DH, Kravitz SA, Mouchard L, Reinert K, Remington KA, Clark AG, Waterman MS, Eichler EE, Adams MD, Hunkapiller MW, Myers EW, Venter JC.

Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1916-21. Epub 2004 Feb 9.

12.

Online measurement of urea concentration in spent dialysate during hemodialysis.

Olesberg JT, Arnold MA, Flanigan MJ.

Clin Chem. 2004 Jan;50(1):175-81.

PMID:
14709645
13.

Sources of Staphylococcus aureus for patients on continuous ambulatory peritoneal dialysis.

Herwaldt LA, Boyken LD, Coffman S, Hochstetler L, Flanigan MJ.

Perit Dial Int. 2003 May-Jun;23(3):237-41.

PMID:
12938823
14.

Response to inadequate dialysis in chronic peritoneal dialysis patients. Results from the 2000 Centers for Medicare and Medicaid (CMS) ESRD Peritoneal Dialysis Clinical Performance Measures (PD-CPM) Project.

Rocco MV, Frankenfield DL, Prowant B, Frederick P, Flanigan MJ; Centers for Medicare & Medicaid Services Peritoneal Dialysis Clinical Performance Measures Study Group.

Am J Kidney Dis. 2003 Apr;41(4):840-8.

PMID:
12666071
15.

Risk factors for early mortality in U.S. peritoneal dialysis patients: impact of residual renal function.

Rocco MV, Frankenfield DL, Prowant B, Frederick P, Flanigan MJ; Centers for Medicare & Medicaid Services Peritoneal Dialysis Core Indicators Study Group.

Perit Dial Int. 2002 May-Jun;22(3):371-9.

PMID:
12227396
16.

A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome.

Mural RJ, Adams MD, Myers EW, Smith HO, Miklos GL, Wides R, Halpern A, Li PW, Sutton GG, Nadeau J, Salzberg SL, Holt RA, Kodira CD, Lu F, Chen L, Deng Z, Evangelista CC, Gan W, Heiman TJ, Li J, Li Z, Merkulov GV, Milshina NV, Naik AK, Qi R, Shue BC, Wang A, Wang J, Wang X, Yan X, Ye J, Yooseph S, Zhao Q, Zheng L, Zhu SC, Biddick K, Bolanos R, Delcher AL, Dew IM, Fasulo D, Flanigan MJ, Huson DH, Kravitz SA, Miller JR, Mobarry CM, Reinert K, Remington KA, Zhang Q, Zheng XH, Nusskern DR, Lai Z, Lei Y, Zhong W, Yao A, Guan P, Ji RR, Gu Z, Wang ZY, Zhong F, Xiao C, Chiang CC, Yandell M, Wortman JR, Amanatides PG, Hladun SL, Pratts EC, Johnson JE, Dodson KL, Woodford KJ, Evans CA, Gropman B, Rusch DB, Venter E, Wang M, Smith TJ, Houck JT, Tompkins DE, Haynes C, Jacob D, Chin SH, Allen DR, Dahlke CE, Sanders R, Li K, Liu X, Levitsky AA, Majoros WH, Chen Q, Xia AC, Lopez JR, Donnelly MT, Newman MH, Glodek A, Kraft CL, Nodell M, Ali F, An HJ, Baldwin-Pitts D, Beeson KY, Cai S, Carnes M, Carver A, Caulk PM, Center A, Chen YH, Cheng ML, Coyne MD, Crowder M, Danaher S, Davenport LB, Desilets R, Dietz SM, Doup L, Dullaghan P, Ferriera S, Fosler CR, Gire HC, Gluecksmann A, Gocayne JD, Gray J, Hart B, Haynes J, Hoover J, Howland T, Ibegwam C, Jalali M, Johns D, Kline L, Ma DS, MacCawley S, Magoon A, Mann F, May D, McIntosh TC, Mehta S, Moy L, Moy MC, Murphy BJ, Murphy SD, Nelson KA, Nuri Z, Parker KA, Prudhomme AC, Puri VN, Qureshi H, Raley JC, Reardon MS, Regier MA, Rogers YH, Romblad DL, Schutz J, Scott JL, Scott R, Sitter CD, Smallwood M, Sprague AC, Stewart E, Strong RV, Suh E, Sylvester K, Thomas R, Tint NN, Tsonis C, Wang G, Wang G, Williams MS, Williams SM, Windsor SM, Wolfe K, Wu MM, Zaveri J, Chaturvedi K, Gabrielian AE, Ke Z, Sun J, Subramanian G, Venter JC, Pfannkoch CM, Barnstead M, Stephenson LD.

Science. 2002 May 31;296(5573):1661-71. Erratum in: Science 2002 Aug 23;297(5585):1278. Science. 2004 Mar 12;303(5664):1612.

17.

Clinical performance measures: the changing status of peritoneal dialysis.

Flanigan MJ, Rocco MV, Prowant B, Frederick PR, Frankenfield DL.

Kidney Int. 2001 Dec;60(6):2377-84.

18.

Nutritional markers during peritoneal dialysis: data from the 1998 Peritoneal Dialysis Core Indicators Study.

Flanigan MJ, Frankenfield DL, Prowant BF, Bailie GR, Frederick PR, Rocco MV.

Perit Dial Int. 2001 Jul-Aug;21(4):345-54.

PMID:
11587396
20.

Role of sodium in hemodialysis.

Flanigan MJ.

Kidney Int Suppl. 2000 Aug;76:S72-8. Review.

PMID:
10936802
21.

A whole-genome assembly of Drosophila.

Myers EW, Sutton GG, Delcher AL, Dew IM, Fasulo DP, Flanigan MJ, Kravitz SA, Mobarry CM, Reinert KH, Remington KA, Anson EL, Bolanos RA, Chou HH, Jordan CM, Halpern AL, Lonardi S, Beasley EM, Brandon RC, Chen L, Dunn PJ, Lai Z, Liang Y, Nusskern DR, Zhan M, Zhang Q, Zheng X, Rubin GM, Adams MD, Venter JC.

Science. 2000 Mar 24;287(5461):2196-204.

PMID:
10731133
22.

Long-term, successful peritoneal dialysis: end-stage renal disease core indicators study data.

Flanigan MJ, Prowant BF, Frankenfield D, Rocco MV.

Adv Perit Dial. 1999;15:105-11.

PMID:
10682082
23.

Nightly tidal peritoneal dialysis prescription and power.

Flanigan MJ.

Contrib Nephrol. 1999;129:115-22. Review. No abstract available.

PMID:
10590870
24.

Rationale for tidal peritoneal dialysis.

Flanigan MJ.

Contrib Nephrol. 1999;129:62-8. Review. No abstract available.

PMID:
10590864
25.

1997 Peritoneal Dialysis-Core Indicators Study: Dialysis Adequacy and Nutritional Indicators Report.

Flanigan MJ, Rocco MV, Frankenfield D, Bailie G, Frederick P, Prowant B, Taylor L.

Am J Kidney Dis. 1999 Jun;33(6):e3.

PMID:
10352219
27.

Trends in clinical indicators of care for adult peritoneal dialysis patients in the United States from 1995 to 1997. ESRD Core Indicators Workgroup.

Frankenfield DL, Prowant BF, Flanigan MJ, Frederick PR, Bailie GR, Helgerson SD, Rocco MV.

Kidney Int. 1999 May;55(5):1998-2010.

28.

1996 peritoneal dialysis--core indicators report.

Flanigan MJ, Rocco MV, Frankenfield DL, Bailie G, Frederick PR, Prowant BF, Taylor L.

Am J Kidney Dis. 1998 Jul;32(1):E3.

PMID:
10074586
29.

1996 Peritoneal Dialysis Core Indicators Study: report on nutritional indicators.

Flanigan MJ, Bailie GR, Frankenfield DL, Frederick PR, Prowant BF, Rocco MV.

Perit Dial Int. 1998 Sep-Oct;18(5):489-96.

PMID:
9848627
30.

The effect of uraemia, acidosis, and dialysis treatment on protein metabolism: a longitudinal leucine kinetic study.

Lim VS, Yarasheski KE, Flanigan MJ.

Nephrol Dial Transplant. 1998 Jul;13(7):1723-30.

PMID:
9681719
31.

Leucine turnover in patients with nephrotic syndrome: evidence suggesting body protein conservation.

Lim VS, Wolfson M, Yarasheski KE, Flanigan MJ, Kopple JD.

J Am Soc Nephrol. 1998 Jun;9(6):1067-73.

32.

Peritoneal dialysis indices: weekly CrCl and weekly Kt/Vurea are linked.

Flanigan MJ.

Am J Kidney Dis. 1998 Mar;31(3):495-501.

PMID:
9506687
33.

Report from the 1995 Core Indicators for Peritoneal Dialysis Study Group.

Rocco MV, Flanigan MJ, Beaver S, Frederick P, Gentile DE, McClellan WM, Polder J, Prowant BF, Taylor L, Helgerson SD.

Am J Kidney Dis. 1997 Aug;30(2):165-73.

PMID:
9261026
34.

Impaired bone growth after ileal augmentation cystoplasty.

Hochstetler JA, Flanigan MJ, Kreder KJ.

J Urol. 1997 May;157(5):1873-9.

PMID:
9112552
35.

Dialysate sodium delivery can alter chronic blood pressure management.

Flanigan MJ, Khairullah QT, Lim VS.

Am J Kidney Dis. 1997 Mar;29(3):383-91.

PMID:
9041214
36.

Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A.

Flanigan MJ, Pillsbury L, Sadewasser G, Lim VS.

Am J Kidney Dis. 1996 Apr;27(4):519-24.

PMID:
8678062
37.

The significance of protein intake and catabolism.

Flanigan MJ, Lim VS, Redlin J.

Adv Ren Replace Ther. 1995 Oct;2(4):330-40. Review.

PMID:
8591124
38.

Determination of observer-rated alpha activity during sleep.

Flanigan MJ, Morehouse RL, Shapiro CM.

Sleep. 1995 Oct;18(8):702-6.

PMID:
8560138
39.

Effect of erythromycin on ethanol's pharmacokinetics and perception of intoxication.

Min DI, Noormohamed SE, Flanigan MJ.

Pharmacotherapy. 1995 Mar-Apr;15(2):164-9.

PMID:
7624263
40.

The influence of ipsapirone, a 5-HT1A agonist, on sleep patterns of healthy subjects.

Driver HS, Flanigan MJ, Bentley AJ, Luus HG, Shapiro CM, Mitchell D.

Psychopharmacology (Berl). 1995 Jan;117(2):186-92.

PMID:
7753966
41.

Abnormal endocrine tests in a hemodialysis patient.

Hochstetler LA, Flanigan MJ, Lim VS.

J Am Soc Nephrol. 1994 Apr;4(10):1754-9.

42.

Transplant-associated thrombotic microangiopathy: the role of IgG administration as initial therapy.

Hochstetler LA, Flanigan MJ, Lager DJ.

Am J Kidney Dis. 1994 Mar;23(3):444-50. Review. Erratum in: Am J Kidney Dis 1994 May;23(5):772.

PMID:
8128949
43.

Is 8 hours of nightly peritoneal dialysis enough?

Flanigan MJ, Pflederer TA, Lim VS.

ASAIO J. 1994 Jan-Mar;40(1):24-6.

PMID:
8186488
44.

Continuous ambulatory peritoneal dialysis catheter infections: diagnosis and management.

Flanigan MJ, Hochstetler LA, Langholdt D, Lim VS.

Perit Dial Int. 1994;14(3):248-54.

PMID:
7948237
45.

Tidal peritoneal dialysis: kinetics and protein balance.

Flanigan MJ, Lim VS, Pflederer TA.

Am J Kidney Dis. 1993 Nov;22(5):700-7.

PMID:
8238016
46.

The effect of hemodialysis on protein metabolism. A leucine kinetic study.

Lim VS, Bier DM, Flanigan MJ, Sum-Ping ST.

J Clin Invest. 1993 Jun;91(6):2429-36.

47.

Diuretic-enhanced I-131 clearance after ablation therapy for differentiated thyroid cancer.

Seabold JE, Ben-Haim S, Pettit WA, Gurli NJ, Rojeski MT, Flanigan MJ, Ponto JA, Bricker JA.

Radiology. 1993 Jun;187(3):839-42.

PMID:
8497641
48.

ABC of sleep disorders. Function of sleep.

Shapiro CM, Flanigan MJ.

BMJ. 1993 Feb 6;306(6874):383-5. Review. No abstract available.

49.

Tidal peritoneal dialysis vs. continuous cyclic peritoneal dialysis: children's preference.

Doyle CL, Flanigan MJ, Mabe C.

ANNA J. 1992 Jun;19(3):249-54.

PMID:
1627006
50.

Ventilatory and metabolic changes during high efficiency hemodialysis.

Symreng T, Flanigan MJ, Lim VS.

Kidney Int. 1992 Apr;41(4):1064-9.

Supplemental Content

Loading ...
Support Center